Add like
Add dislike
Add to saved papers

Under-estimation of 210 Pb in industrial radioactive scales.

Analytica Chimica Acta 2018 Februrary 14
Lead-210 (21 0 Pb) can be present at high activity concentrations, in residues arising from the petroleum, mineral processing and chemical industries. Although 210 Pb itself poses a low radiological risk, the nuclide decays via 210 Bi to the alpha emitting and highly radiotoxic 210 Po. Therefore, rapid, accurate determination of 210 Pb is essential for assessing the radiological risk to plant operators and appropriate sentencing of waste. Unfortunately, direct measurement of 210 Pb by gamma spectrometry is hindered by its weak gamma-ray emission at 46.5 keV, which is readily attenuated by mineral matrices. This paper demonstrates the extent to which 210 Pb can be underestimated during routine analysis by an inter-laboratory exercise involving five accredited laboratories and a wide range of scales from diverse industrial sources. Two methods of addressing errors in 210 Pb analysis are highlighted; the first, involving lithium tetraborate fusion prior to gamma spectrometry shows promise but is not suitable for all 210 Pb-containing phases. The second method, requiring calculation of matrix attenuation factors for a representative fingerprint sample, was applied successfully to deposits from the steel and gas industries. However, its wider application depends on detailed chemical and mineralogical characterisation for each of the major categories of mineral scale found and at present, there is an acute lack of suitable certified reference materials.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app